Two Sigma Investments’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Two Sigma Investments's IRD Position: Q3 2026 in Review
Two Sigma Investments reduced its Opus Genetics (IRD) stake by 47% in Q3 2026, selling an estimated $500K and leaving 133,632 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #3877.
Two Sigma Investments first reported a position in IRD in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.04M in Q2 2026. 113 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Two Sigma Investments held 133,632 shares of Opus Genetics worth $647K as of Q3 2026.
- Two Sigma Investments sold 120,330 Opus Genetics shares in Q3 2026, an estimated $500K.
- Opus Genetics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #3877 holding.
- Two Sigma Investments first reported a position in Opus Genetics in Q2 2014 and has held it in 11 quarters since.
- Two Sigma Investments's Opus Genetics position peaked at $1.04M in Q2 2026.
- 113 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.